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Edited by Richard CogdellAbstract Bacterial multidrug eﬄux pumps operate by periplas-
mic recruitment and opening of TolC family outer membrane
exit ducts by cognate inner membrane translocases. Directed
evolution of active hybrid pumps was achieved by challenging a
library of mutated, shuﬄed TolC variants to adapt to the non-
cognate Pseudomonas MexAB translocase, and confer resis-
tance to the eﬄux substrate novobiocin. Amino acid substitutions
in MexAB-adapted TolC variants that endowed high resistance
were recreated independently, and revealed that MexAB-adapta-
tion was conferred only by substitutions located in the lower
a-helical barrel of TolC, speciﬁcally the periplasmic equatorial
domain and entrance coiled coils. These changes converge to
the native MexAB partner OprM, and indicate an interface
key to the function and diversity of eﬄux pumps.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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pump1. Introduction
Multidrug resistance (MDR) eﬄux pumps of Gram-negative
bacteria such as Escherichia coli and Pseudomonas aeruginosa
expel a wide range of antibacterial drugs, including antibiotics,
and other inhibitors like bile salts and detergents [1–3]. In these
tripartite pumps an outer membrane (OM) protein of the TolC
family is recruited by a substrate-loaded inner membrane (IM)
translocase of two proteins, a proton antiporter or ATPase
and an adaptor protein. In parallel, TolC homologues also
co-operate with distinct translocases to export virulence pro-
teins [3,4]. The assembled machineries establish contiguous
proteinacious exit channels spanning the IM and OM and
the intervening periplasmic space [4,5]. Bacteria commonly
have several eﬄux pumps aﬀording wide resistance, two char-
acterised examples are the related RND-type multidrug eﬄux
pumps TolC/AcrAB of E. coli, in which the TolC protein is uti-
lised by the IM complex of proton antiporter AcrB and adap-
tor AcrA [5–7], and OprM/MexAB of P. aeruginosa, in which
the TolC homologue OprM is recruited by the translocase
MexAB [2,8].
High resolution structures of the RND type pump compo-
nents are available. The trimeric E. coli TolC presents a cell*Corresponding author. Fax: +44 1223 333346.
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doi:10.1016/j.febslet.2006.09.005exit duct [9] in which an OM b-barrel of ca. 40 A˚ anchors a
contiguous a-helical barrel projecting 100 A˚ into the peri-
plasm. In the lower half of the a-helical barrel, which is
bounded by an equatorial domain of mixed a/b-structure,
the helices form six pairs of regular two-stranded coiled coils
with one from each monomer folding inwards to form the
periplasmic entrance constriction [10]. TolC homologue
OprM from P. aeruginosa [11] has only 15% sequence identity
to TolC but its structure is closely conserved. The homotri-
meric proton antiporter AcrB is anchored in the IM by
trans-membrane a-helices and has a central cavity which
may be juxtaposed to the TolC periplasmic entrance via weak
contact at the apex of its ca. 70 A˚ periplasmic domain
[5,12,13]. Adaptor proteins AcrA and MexA are anchored
to the IM and interact with their IM antiporter partner and
the OM TolC [6]. They share a common elongated structure
with a long periplasmic a-helical hairpin [14–16], which is
proposed to be key to TolC recruitment, stabilizing contact
between the antiporter and TolC, and triggering transition
to the TolC open state [10].
Although the TolC/AcrAB and OprM/MexAB pumps are
closely related, the MexAB translocase is unable to function
with E. coli TolC [17], indicating that subtle diﬀerences may
underlie pump component speciﬁcity and diversity. We set
out to identify TolC residues involved in pump assembly by
a directed evolution approach, in which a library of TolC mu-
tant variants was subjected to selection for MexAB adaptation
and functional pump assembly.2. Methods
2.1. Assembling a library of variant TolC proteins
Initially, mutations were generated in the 1491 bp tolC gene using
Taq polymerase (Qiagen) in a PCR reaction containing 0.25 mM
MnCl2 (50 cycles of 94 C for 30 s, 50 C for 45 s, 72 C for 45 s,
and a ﬁnal extension at 72 C, 7 min). Uracil-containing template
was generated in subsequent PCR containing a dTTP/dUTP mixture,
and 100–300 bp fragments generated by endonuclease V at 37 C,
16 h [18]. These were assembled using 1–2 lg DNA and two units of
Taq polymerase in 50 cycles (94 C for 30 s, 45 C for 30 s, 72 C for
30 s). The resulting shuﬄed, mutated tolC genes were then ampliﬁed
by PCR using tolC-ﬂanking primers, and ligated using NdeI and Bam-
HI into the expression plasmid pET11 (Novagen), thus creating vari-
ants of pETTolC.2.2. Site-directed mutagenesis
Site directed mutants of the tolC gene were created in a PCR-based
system using double stranded DNA template pETTolC and long muta-
genic primers (QuikChange system, Stratagene). The mutations were
conﬁrmed by sequencing.blished by Elsevier B.V. All rights reserved.
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TolC wild-type (WT) and variants were expressed in E. coli
MCDacrABtolC (E. coli MC1061 in which the endogenous acrAB
and tolC genes were deleted [6]). This strain was converted to a
(DE3)-lysogen, but all experiments employed basal levels of expression
without induction. The pETTolC variants were cotransformed with
pACMexAB (vector pACYC184 into which mexAB was cloned using
EcoRV and BamHI following PCR ampliﬁcation from the P. aerugin-
osa chromosome). Novobiocin resistance was assayed as growth on LB
agar containing 0, 5, 10, 20, 40, 60, 80 and 100 lg/ml drug. Nalidixic
acid (Nal) and ethidium bromide (EtBr) resistance were assessed in li-
quid cultures containing a twofold dilution series of inhibitor. All resis-
tance values are given in lg/ml and denote the highest concentration of
inhibitor at which growth (overnight at 37 C) was detected.
2.4. Assay of TolC–MexA complexes
In vivo cross-linking with the cleavable amine-speciﬁc cross-linker
dithiobis-succinimidylpropionate (DSP) was carried out as described,
followed by aﬃnity pull-down [4]. Cross-linked protein complexes were
separated on 10% acrylamide–SDS gels, transferred to Pro-Blot PVDF
membranes, and MexA protein blotted with rabbit polyclonal antisera.
2.5. Assay of hemolysin export
Hemolysin secretion was determined as described [10]. Cells from
exponential broth cultures of E. coli MCDtolC [6] carrying pETTolC
and pAC50 (expressing genes for hemolysin (HlyA) and translocase
(HlyBD)) were resuspended in warm LB and incubated for 10 min.
Supernatant HlyA was precipitated, separated on acrylamide-SDS
gels, and blotted with speciﬁc antiserum.3. Results
3.1. Selecting MexAB-adapted TolC variants conferring
Novobiocin resistance
To generate an extensive library of TolC variants error-
prone PCR mutagenesis was combined with a DNA recombi-
nation (gene-shuﬄing) step [19,20]. Transformation into E. coli
XL-10 (Stratagene) gave an estimated 106 clones, which were
pooled to generate the mutant tolC DNA library. To assess
the mutation frequency in this library, the tolC genes of ﬁve
random clones were sequenced. This revealed 53 mutations
in a total of 7455 bp (29 transversions, 22 transitions and
two deletions, causing frameshifts), indicating a mutation fre-
quency of approximately 0.7%. To identify TolC variants
adapted to MexAB we selected resistance to novobiocin, a
common eﬄux substrate of MexAB/OprM and AcrAB/TolC
pumps [21].Fig. 1. MexAB-adapted TolC isolates. TolC variants TC1-4. The b-barrel fo
contiguous a-helical domain. Numbering of TolC residues relates to the mat
with the mixed a/b equatorial domain highlighted in gold.Deletion of acrAB and tolC from E. coli MC1061 reduced
novobiocin resistance (NovR) from 100 to below 1 lg/ml.
When this strain MCDacrABtolC was transformed with WT
TolC on plasmid pETTolC background resistance increased
to approximately 5 lg/ml (due to TolC interaction with
remaining endogenous translocases of E. coli [1]). E. coli
MCDacrABtolC carrying pACMexAB (expressing P. aerugin-
osa MexAB) was then transformed with the mutant tolC li-
brary and screened for increased novobiocin resistance,
initially on LB agar containing 10 lg/ml novobiocin. Thirty-
one colonies grew, and mutant DNA was isolated from each.
When these variant tolC genes were co-transformed with the
pACYC184 vector, NovR was background level, but when
re-transformed with pACMexAB, all allowed growth on
10 lg/ml novobiocin.
Of the 31 variant isolates four showed a greater than 10-fold
increase in NovR (TC1 and TC2 80 lg/ml, TC3 and TC4 60 lg/
ml). The four responsible tolC genes were sequenced. TC1–
TC4 contained one to ﬁve amino acid substitutions, giving a
total of 10 (Fig. 1). Only one change occurred more than once
(Q142R in TC1 and TC2). The 10 changes were located
throughout the TolC protein, four in the b-barrel domain,
one in the a/b-equatorial domain and ﬁve in the a-helical do-
main.3.2. Eﬀect of individual TolC amino acid changes on MexAB
adaptation
To establish to what degree each of the 10 TolC amino acid
substitutions in the NovR variant isolates contributed to Mex-
AB adaptation, corresponding mutants were made individu-
ally in tolC by site-directed mutagenesis and the resulting
TolC variants expressed with MexAB as before. Western blot-
ting using TolC antisera conﬁrmed that expression levels were
indistinguishable from WT (not shown). Novobiocin resis-
tance (Table 1) showed that the two changes in isolate TC1
(NovR 80 lg/ml), Q142R at the tip of the coiled coil and
V198D in the equatorial domain, determined NovR 10 and
40lg/ml, respectively. Q142R was also present in TC2 (NovR
80 lg/ml), while of the other two TC2 lesions I369F, in the low-
er a-barrel, conferred resistance of 60 lg/ml, and L44S, located
in the b-barrel, had no eﬀect. In the TC1 and TC2 isolates,
Q142R appears not to have a substantial impact on its own,
but has synergy with each of the equatorial V198D and coilrms a single OM pore, the periplasmic entrance is at the bottom of the
ure, processed protein sequence. One TolC protomer is shown in blue,
Table 1
Eﬀect of individual changes in TolC on novobiocin resistance
TolC Domain NovR
WT 5
L44S b-Barrel 5
N52K b-Barrel 5
D56N b-Barrel 5
A67V b-Barrel 5
V198D Equatorial 40
A83V a-Helical 5
D121N a-Helical 60
I133A a-Helical 60
Q142R a-Helical 10
I369F a-Helical 60
Q142RV198D a-Helical 80
Q142RI369F a-Helical 80
Resistance was determined in E. coli MCDacrABtolC, MexAB was co-
expressed from plasmid pACMexAB. All TolC proteins determined
novobiocin resistance of 5 lg/ml in the absence of MexAB. The b-
barrel, a-barrel and equatorial domains are shown in Fig. 1.
Fig. 2. TolC interaction with MexA. Western blots of MexA following
in vivo DSP cross-linking (x-link) and aﬃnity pull down by His-tagged
wild-type or MexAB-adapted TolC.
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ate double mutants Q142RV198D and Q142RI369F, which both
had NovR 80 lg/ml, matching those of the original TC1 and
TC2. This also conﬁrmed that the b-barrel change L44S is
not pertinent to MexAB adaptation.
Variant TC3 had only one change, D121N, located in the
lower a-barrel. An identical site-directed mutant D121N deter-
mined the same resistance (60 lg/ml). Of the ﬁve substitutions
in variant TC4 (NovR 60 lg/ml), four corresponding individ-
ual site-directed mutants failed to raise resistance above back-
ground 5 lg/ml. Three of these (D56N, N52K, A67V) were
located in the b-barrel and one (A83V) was at the top of the
a-helical domain. In contrast, the lower a-barrel mutation
I133A allowed growth on 60 lg/ml, identical to TC4.
Two TolC single mutants of NovR 60 lg/ml, I133A and
D121N, and both double mutants (NovR 80 lg/ml),
Q142RV198D and Q142RI369F, were tested with co-expressed
MexAB for sensitivity to two structurally unrelated eﬄux sub-
strates of MexAB, Nal and EtBR. In each case, the hybrid
pumps of MexAB and TolC NovR variants showed two- to
four-fold increases in resistance to both compounds (Table
2). When these TolC variants were transformed into E. coli
strain MCDtolC [6] expressing the natural TolC translocase
AcrAB, NovR was in each case 100 lg/ml, the same as WT
TolC/AcrAB. Similarly when substituted for WT TolC in the
TolC/HlyBD protein export system, hemolysin export (per-
formed as in [10]) appeared undiminished (not shown). These
assays showMexAB-adaptation can be conferred by single res-Table 2
Resistance to distinct eﬄux substrates
TolC NovR NalR EtBrR
WT 5 0.4 6.25
D121N 60 0.8 12.5
I133A 60 0.8 12.5
Q142RV198D 80 1.6 25
Q142RI369F 80 1.6 12.5
Novobiocin resistance was assayed on agar plates; resistance against
nalidixic acid and ethidium bromide were assessed in over-night liquid
growth cultures containing a twofold dilution series of the inhibitor.
Values (lg/ml) indicate the highest concentration of inhibitor at which
growth was still observed.idue changes, that MexAB-adaptation is not speciﬁc to the
selection substrate novobiocin, and that MexAB-adaptation
did not prevent TolC retaining function with its native part-
ners.
We assessed interaction of MexAB with adapted TolC pro-
teins, by co-expressing MexAB and C-terminally His-tagged
WT [6] or adapted TolC in cells treated in vivo, as previously
described [4], with the cleavable amine-speciﬁc cross-linker
DSP. However, Western blotting of aﬃnity-puriﬁed cross-
linked membrane proteins revealed interaction of not only
the MexAB-adapted TolC variants, e.g. Q142RV198D, but also
of WT (Fig. 2). This may reﬂect an initial ‘docking’ step (to
which also MexB could contribute [13]) in the constitutive
interaction of partners of tripartite MDR pumps [6], in con-
trast to the substrate-induced recruitment of TolC in protein
export machineries [4]. The resulting docked complex, detect-
able by cross-linking, would need to be strengthened post-
docking in functional pumps, possibly to eﬀect TolC opening.
3.3. Signiﬁcance of the ﬁve MexAB-adaptive amino acid changes
in TolC
Four of the changes, V198D, I369F, D121N and I133A, were
important to MexAB adaptation. In addition Q142R had only
a marginal eﬀect on its own but acted synergistically with
V198D and I369F. Their location is not random. While the ﬁve
inconsequential changes are located in the b-barrel and the
upper part of the a-barrel, all ﬁve of the adaptive substitutions
are conﬁned to the a-barrel below and including the equatorial
domain (Fig. 3A and B). The adaptive changes were mapped
on the TolC crystal structure [9] and, using alignment program
Clustal X v 1.8.3 [22], compared to the corresponding residues
of the natural partner OprM, and the wider OprM and TolC
subfamilies.
Residue V of V198D is located in the equatorial domain, its
side chain has a Van der Waals contact with the R390 side
chain in helix 8 (numbering of helices is that of Koronakis
et al. [9]). OprM has an aspartic acid residue at that position
(D253), like the TolC change. Amino acid I369 is close to the en-
trance tip in helix 8. It is completely buried and makes Van der
Waals contacts with the side chain of Y362 in WT TolC. The
equivalent residue in OprM is tyrosine411. Residue D of
D121N hydrogen bonds with Y391 of helix 8, stabilizing the
TolC entrance helices. The change to asparagine is conserva-
tive and would preserve local interactions while losing a nega-
tive charge. The natural MexAB partner OprM has an
uncharged alanine in the corresponding position (A173). Resi-
due Q142 is surface exposed, right at the entrance of TolC at
the tip of helix 3. Like Q142R, OprM has an arginine residue
at that position, R194. Thus four of the ﬁve adaptive TolC
mutations match or approximate the corresponding OprM
Fig. 3. TolC residue changes that determine MexAB adaptation. (A) Sequence alignment of the short regions of the exit duct a-helical barrel
encompassing adaptive mutations isolated in TolC (allowing substitution of OprM, this paper) and in VceC (allowing substitution of TolC, [23]).
Numbers in brackets refer to published residue nomenclature, the arrows indicate the conserved a-helices, numbered as in Ref. [9]. (B) (left) Changes
that confer NovR are space-ﬁlled in red, those that have no eﬀect are green. The colouring scheme for the TolC protomer is the same as in Fig. 1.
(right) Magniﬁcation showing TolC entrance coils in the closed state, with the location of ﬁve MexAB-adaptive TolC residues in red. The four gain-
of-function changes of VceC (Fig. 3A) are indicated in orange.
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pletely buried, halfway between the entrance tip and the equa-
torial domain in helix 3, making Van der Waals side chain
contacts with Q160 and T376. Although OprM has tyrosine in
this position (Y185), there are examples of phenylalanine in
the TolC subfamily and alanine in the OprM subfamily, indi-
cating both small (I/A) and large (Y/F) residues are allowed at
that position.4. Conclusions: a key role for the TolC exit duct entrance helices
The modular arrangement of eﬄux pumps has allowed bac-
teria to evolve arrays of trans-envelope channels able to repel a
variety of toxic compounds in the environment, with each
pump recruiting a TolC exit duct or ‘trash chute’ for inhibitory
molecules engaged at an IM translocase. Each of the three
components belongs to a large protein family with strongly
conserved structures. Pump component speciﬁcity and pump
diversity seem likely to reﬂect subtle changes governing the
assembly interaction surfaces. Our results appear to lend sup-
port to this view. Isolation of rare MexAB-adapted TolC vari-
ants from a heavily mutagenised and shuﬄed library, and
recreation of each change individually by site-directed muta-
genesis, revealed ﬁve inﬂuential residue changes. Signiﬁcantly,
four changes I369F, D121N, I133A and Q142R lie in the lower
part of the a-barrel, pointing to a deﬁned subdomain forming
the interface of the inner and outer coils of the TolC entrancehelices [9]. The ﬁfth adaptive change V198 D lies in the equato-
rial domain directly above this interface/groove. The speciﬁc
nature of the residue changes indicates convergence to the cor-
responding sequence of OprM, compatible with a key role in
governing pump speciﬁcity.
In a parallel study naturally occurring mutants of the Vibrio
cholerae TolC homologue VceC showed an analogous gain-of-
function in the presence of the E. coli AcrAB translocase [23],
partly restoring survival against the inhibitory AcrAB eﬄux
substrate deoxycholate [1]. Four amino acid changes were re-
ported; the equivalent residues in TolC are Q129, Q139, N156
and D374, all located near the periplasmic tip of the channel
(Fig. 3A and B). These diﬀer from those found in our experi-
ments, but signiﬁcantly, Q129 and Q139 are interspersed with
D121 and I133 on helix 3, whereas residue N156 lies on helix 4,
directly opposite and within 4 A˚ of our I369 (Fig. 3). We have
shown that D374 lines the inner channel constriction [24], pos-
sibly contributing to substrate gating.
The ﬁndings of both studies give strong support to structure-
based hypotheses of interaction in which the lower TolC heli-
ces are the target for functional recruitment by cognate pump
components, in particular by the long a-helical hairpin of the
periplasmic adapter [5,14,25]. Our study, exploiting a high den-
sity of variants, revealed that this region extends the length of
the lower coils, up to the equatorial domain. The inner and
outer a-helices in this TolC subdomain adopt a coiled–coil
structure characterised by a superhelical twist that is key to
transition between the closed and open states of the TolC peri-
E. Bokma et al. / FEBS Letters 580 (2006) 5339–5343 5343plasmic entrance [10]. Signiﬁcantly, the MexAB-adapted TolC
residues have relatively low surface exposure, which may indi-
cate access requires conformational change, e.g. by partial
unwinding and re-packing of the entrance coils with the adap-
tor helical coil. Either that or they inﬂuence surface character-
istics indirectly. Both our study and that of Vediyappan et al.
[23] found that the IM translocase proteins could be isolated in
complex with the adapted non-cognate OM partner as well as
with the non-adapted WT, and gain-of-function did not cause
loss of function with the natural partner translocase(s). This
may indicate that the residues identiﬁed are not directly in-
volved in the physical docking of the translocase to the OM
channel, but are rather part of an interface central to post-
docking events that are key to the function of the pump. The
recently demonstrated modular structure and high ﬂexibility
of the adaptor protein [26] may play an important role in
assuring its alignment and interaction with the TolC protein
exit duct.
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